TenderOffer.co
Comparison

Friendly vs hostile tender offer

Friendly tenders are launched with target board support; hostile tenders go directly to shareholders against the board's wishes.

Attribute Friendly tender offer Hostile tender offer
Board posture Supports the offer; signs merger agreement Opposes; recommends rejection in 14D-9
Schedule 14D-9 recommendation Recommend acceptance Recommend rejection
Premium typical range 25–40% over 30-day VWAP 40%+ — needed to overcome board resistance
Defenses likely activated None — board cooperates Poison pill, white-knight search, litigation, proxy fight
Closing path Tender → §251(h) or short-form merger Long contested process; often pivots to proxy fight or withdrawal
Modern frequency in U.S. Dominant — most public M&A Rare — modern poison-pill defense makes pure hostile bids very hard
Lock-up support typical Yes — voting agreements with key holders No — bidder works the entire holder base independently
Litigation profile Disclosure-only suits standard; rarely substantive Substantive: fiduciary duty, defensive measures (Unocal/Revlon)

When the comparison matters

Almost all U.S. public-company tender offers today are friendly — negotiated up front, signed via merger agreement, supported by the board, and structured around a clean §251(h) back-end merger. The hostile column above describes a textbook structure that rarely reaches expiration in modern U.S. practice; would-be hostile bidders typically pivot to bear-hug letters or activist campaigns to force the board to negotiate.

Why hostile tenders are rare today

The combination of universally-available poison pills, staggered boards (in some companies), Delaware fiduciary-duty doctrine, and the practical difficulty of running a 60-day tender in the face of board opposition has made pure hostile takeovers a niche structure. The activist-shareholder campaign — Schedule 13D + proxy contest + media pressure — has largely supplanted the hostile tender as the lever for unwilling targets.

Guides

Glossary